How is the AC Immune SA today?

The AC Immune SA today is trading in the down by -0.59% at 1.69.

What is AC Immune SA Annual Revenue?

AC Immune SA Annual Revenue rose 84.51%, in the last year to $27.31 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is AC Immune SA Annual Net Profit?

AC Immune SA Annual Net Profit rose 6.12% in the last year to $50.92 M. Its sector's average net profit growth for the last fiscal year was -11.1%.

What is AC Immune SA Price to Earning Ratio?

AC Immune SA Price to Earning Ratio is -2.7, which is negative.

What is AC Immune SA Stock Price?

AC Immune SA Stock Price fell 52.66% and underperformed its sector by 71.33% in the past year.

What is AC Immune SA Quarterly Net profit?

AC Immune SA Quarterly Net profit fell 6.53% YoY to $19.03 M. Its sector's average net profit growth YoY for the quarter was -213.16%.

What is AC Immune SA Debt to Equity Ratio?

AC Immune SA Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is AC Immune SA Return on Equity(ROE)?

AC Immune SA Return on Equity(ROE) for the last financial year was -37.31%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is AC Immune SA Mutual Fund Holding?

AC Immune SA Mutual Fund Holding decreased by 0.73% in the last quarter to 2.17.

What is AC Immune SA Interest Coverage Ratio?

AC Immune SA Interest Coverage Ratio is -381.8, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is AC Immune SA Institutional Holding?

AC Immune SA Institutional Holding decreased by 0.63% in the last quarter to 26.42.

AC Immune SA XNAS: ACIU

AC Immune SA Live Share Price Today, Share Analysis and Chart

Name: AC Immune SA: Is Infosys Ltd. worth buying?
Item: AC Immune SA
Rating: 1.66500
Author: Trendlyne DVM scores

about

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines ...

1.69 -0.01 (-0.59%)

66.06% Fall from 52W High

68,999 XNAS Volume

XNAS 23 May, 2025 5:30 PM (EDT)

Not Eligible

-

Mid Valuation

34.0 / 100

Technically Bearish

32.6 / 100

9

1Yr Price target upside is 447%

4 analysts

AC Immune SA Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

AC Immune SA FAQ

How is AC Immune SA today?

AC Immune SA today is trading in the red, and is down by -0.59% at 1.69.

How has AC Immune SA performed historically?

AC Immune SA is currently trading down -0.59% on an intraday basis. In the past week the stock fell -1.17%. stock has been down -36.23% in the past quarter and fell -52.66% in the past year. You can view this in the overview section.